The kidney as a target organ in pharmaceutical research

Marco Prunotto1, Giulio Gabbiani, Silvia Pomposiello

  • 1Institute of Clinical Pathology, University Hospital Geneva, Geneva 1211, Switzerland. marco.prunotto@gmail.com

Drug Discovery Today
|December 7, 2010
PubMed

Insights

Chronic kidney disease (CKD) is a significant cause of death. Understanding renal fibrosis mechanisms is crucial for developing new pharmaceutical treatments to prevent disease progression and reduce the need for dialysis.

Area of Science:

  • Nephrology
  • Pathophysiology
  • Pharmacology

Background:

  • Kidney diseases contribute significantly to human morbidity and mortality.
  • Chronic kidney disease (CKD) mortality rivals cancer mortality in developed nations.
  • Renal fibrosis is a common pathway in progressive kidney damage.

Purpose of the Study:

  • To review current knowledge on mechanisms, tools, and targets for treating CKD.
  • To highlight the importance of understanding CKD progression.
  • To identify key elements for innovative pharmaceutical approaches.

Main Methods:

  • Literature review of mechanisms, tools, and targets in CKD.
  • Discussion of pathophysiological compound identification.
  • Analysis of biomarker discovery and clinical validation criteria.

Main Results:

  • Renal fibrosis is a central feature of progressive kidney disease.
  • Understanding CKD mechanisms is vital for prevention and delaying renal failure.
  • Pharmaceutical development requires focus on specific targets and validation.

Conclusions:

  • Effective CKD treatment strategies require a comprehensive understanding of disease mechanisms.
  • Innovative pharmaceutical approaches depend on identifying key pathophysiological compounds and biomarkers.
  • Rigorous clinical validation is essential for successful drug development in nephrology.

Related Concept Videos

Drug Elimination by Renal Route: Glomerular Filtration01:17

Drug Elimination by Renal Route: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...